XW0DX82Introduction of Uridine Triacetate into Mouth and Pharynx, External Approach, New Technology Group 2

New Technology›Anatomical Regions›Introduction
  • Billable / Specific Code
ICD-10-PCS XW0DX82
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

XW0DX82 is a billable ICD-10-PCS procedure code for Introduction of Uridine Triacetate into Mouth and Pharynx, External Approach, New Technology Group 2. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. The Alphabetic Index lists this code under Uridine Triacetate. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Administration of therapeutic substances, NEC.

Code Identity

ICD-10-PCS Code
XW0DX82
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Uridine Triacetate into Mouth and Pharynx, External Approach, New Technology Group 2
Short Description
Introduce Uridine Triac in Mouth/Phar, Extern, New Tech 2
Parent Code
XW0

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation0Introduction
4BodyPartDMouth and Pharynx
5ApproachXExternal
6Device/Substance/Technology8Uridine Triacetate
7Qualifier2New Technology Group 2

In the ICD-10-PCS Alphabetic Index

The FY 2027 ICD-10-PCS Alphabetic Index refers to XW0DX82 as Uridine Triacetate. These index entries lead to this code:

Uridine Triacetate
Direct entry for this code
New Technology, Uridine Triacetate
Direct entry for this code
Iloprost
Leads to this code's table
Sarilumab
Leads to this code's table
Vistogard(R)
Anatomy or device term that leads here
Posoleucel
Leads to this code's table
Rezafungin
Leads to this code's table
Treosulfan
Leads to this code's table
Baricitinib
Leads to this code's table
Sabizabulin
Leads to this code's table
Tocilizumab
Leads to this code's table
Caplacizumab
Leads to this code's table
COVID-19 Vaccine
Leads to this code's table
Inebilizumab-cdon
Leads to this code's table
Sulbactam-Durlobactam
Leads to this code's table

To code uridine triacetate, open the FY 2027 ICD-10-PCS Alphabetic Index at Uridine Triacetate. The entry lists XW0DX82 directly as a complete, billable code.

Browse the full ICD-10-PCS Alphabetic Index →

Clinical Classification (CCSR)

AHRQ groups this procedure code into these clinical categories.

ADM021
Administration of therapeutic substances, NEC
Clinical domain: Administration of Therapeutic Substances

Code History

Replaces previously assigned code(s):
  • 3E0DXGC — Introduce Oth Therap Subst in Mouth/Phar, Extern

Similar Procedure Codes

Questions About XW0DX82

Is XW0DX82 a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Uridine Triacetate into Mouth and Pharynx, External Approach, New Technology Group 2 on inpatient claims from October 1, 2026 through September 30, 2027.

What is the ICD-10-PCS code for uridine Triacetate?

The ICD-10-PCS Alphabetic Index lists Uridine Triacetate under code XW0DX82, Introduction of Uridine Triacetate into Mouth and Pharynx, External Approach, New Technology Group 2, billable on inpatient claims in fiscal year 2027.

What do the characters in XW0DX82 mean?

The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character D is the BodyPart (Mouth and Pharynx); the 5th character X is the Approach (External); the 6th character 8 is the Device/Substance/Technology (Uridine Triacetate); the 7th character 2 is the Qualifier (New Technology Group 2).